Search research articles
Contact Us
Filters
Showing results (121-130 of 158) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer
J von Pawel, U Gatzemeier, J L Pujol, et al.
British Journal of Cancer
|
October 19, 2013
A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity
A Gibb, A Greystoke, M Ranson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1994
Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy
M E Van Hoef, I Baumann, C Lange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1996
A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: a comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervals
E Wrigley, A Weaver, G Jayson, et al.
Neurobiology of Disease
|
September 19, 2025
The relationship between anaemia, haemoglobin levels, and cognitive function: Evidence in two population-based cohorts from India and the United States
Laura M Winchester, Danielle Newby, Upamanyu Ghose, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
October 29, 2010
Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer
M Ranson, R H Wilson, J M O'Sullivan, et al.
British Journal of Cancer
|
January 20, 2011
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma
A Greystoke, J P B O'Connor, K Linton, et al.
Heliyon
|
August 22, 2024
Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction
Oliver Pain, Ashley Jones, Ahmad Al Khleifat, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 7, 2023
Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk Prediction
Oliver Pain, Ashley Jones, Ahmad Al Khleifat, et al.
Diseases of the Colon and Rectum
|
October 3, 2023
Combined Robotic Ventral Mesh Rectopexy and Sacrocolpopexy for Multicompartmental Pelvic Organ Prolapse
Liam A Devane, Stacy M Ranson, Leonardo Alfonso Bustamante-Lopez, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 158) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer
J von Pawel, U Gatzemeier, J L Pujol, et al.
British Journal of Cancer
|
October 19, 2013
A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity
A Gibb, A Greystoke, M Ranson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1994
Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapy
M E Van Hoef, I Baumann, C Lange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1996
A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: a comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervals
E Wrigley, A Weaver, G Jayson, et al.
Neurobiology of Disease
|
September 19, 2025
The relationship between anaemia, haemoglobin levels, and cognitive function: Evidence in two population-based cohorts from India and the United States
Laura M Winchester, Danielle Newby, Upamanyu Ghose, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
October 29, 2010
Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer
M Ranson, R H Wilson, J M O'Sullivan, et al.
British Journal of Cancer
|
January 20, 2011
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma
A Greystoke, J P B O'Connor, K Linton, et al.
Heliyon
|
August 22, 2024
Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction
Oliver Pain, Ashley Jones, Ahmad Al Khleifat, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 7, 2023
Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk Prediction
Oliver Pain, Ashley Jones, Ahmad Al Khleifat, et al.
Diseases of the Colon and Rectum
|
October 3, 2023
Combined Robotic Ventral Mesh Rectopexy and Sacrocolpopexy for Multicompartmental Pelvic Organ Prolapse
Liam A Devane, Stacy M Ranson, Leonardo Alfonso Bustamante-Lopez, et al.
Page
of 16